APA (7th ed.) Citation

Pérez-Belmonte, L. M., Torres-Peña, J. D., López-Carmona, M. D., Ayala-Gutiérrez, M. M., Fuentes-Jiménez, F., Huerta, L. J., . . . Cosío, S. F. (2020). Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: A nationwide cohort study. BMC Medicine, 18(1), 1. https://doi.org/10.1186/s12916-020-01832-2

Chicago Style (17th ed.) Citation

Pérez-Belmonte, Luis M., et al. "Mortality and Other Adverse Outcomes in Patients with Type 2 Diabetes Mellitus Admitted for COVID-19 in Association with Glucose-lowering Drugs: A Nationwide Cohort Study." BMC Medicine 18, no. 1 (2020): 1. https://doi.org/10.1186/s12916-020-01832-2.

MLA (9th ed.) Citation

Pérez-Belmonte, Luis M., et al. "Mortality and Other Adverse Outcomes in Patients with Type 2 Diabetes Mellitus Admitted for COVID-19 in Association with Glucose-lowering Drugs: A Nationwide Cohort Study." BMC Medicine, vol. 18, no. 1, 2020, p. 1, https://doi.org/10.1186/s12916-020-01832-2.